Men with high risk for heart disease had lower blood pressure after drinking non-alcoholic red wine every day for four weeks, according to a new study in the American Heart Association journal Circulation Research.
Non-alcoholic red wine increased participants' levels of nitric oxide, which helped decrease both systolic and diastolic blood pressure, researchers said. Nitric oxide is a molecule in the body that helps blood vessels relax and allows more blood to reach your heart and organs.
Researchers studied 67 men with diabetes or three or more cardiovascular risk factors who ate a common diet plus one of the following drinks: about 10 ounces of red wine, non-alcoholic red wine or about 3 ounces of gin. All of the men tried each diet/beverage combination for 4 weeks.
The red wine and nonalcoholic wine contained equal amounts of polyphenols, an antioxidant that decreases blood pressure.
During the red wine phase, the men had very little reduction in blood pressure and there was no change while drinking gin. However, after drinking non-alcoholic red wine, blood pressure decreased by about 6mmHg in systolic and 2mmHg in diastolic blood pressure -- possibly reducing the risk of heart disease by 14 percent and stroke by as much as 20 percent.
Researchers concluded that the alcohol in red wine weakens its ability to lower blood pressure. But polyphenols -- still present after alcohol is removed from wine -- are likely the beneficial element in wine.
Co-authors are Gemma Chiva-Blanch, Mireia Urpi-Sarda, Emilio Ros, Sara Arranz, Palmira Valderas-Martinez, Rosa Casas, Emilio Sacanella, Rafael Llorach, Rosa M Lamuela-Raventos, Cristina Andres-Lacueva and Ramon Estruch. Author disclosures and funding sources are on the manuscript.
For the latest heart and stroke news, follow us on twitter: @HeartNews.
For updates and new science from the Circulation Research journal follow @CircRes on Twitter or go to http://www.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.